Home

Enrique A Conterno

CIK 1476151 · Chief Executive Officer · last filed 2023-07-10

Enrique A Conterno is a Chief Executive Officer who has filed 65 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing shows the insider sold $5.3K of FGEN on Jul 10, 2023. Across all open-market trades the lifetime net is −$14.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $195.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$195.10M

Companies

2

Total Filings

65

Lifetime Open-Market Net

-$14.16M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KYNTRA BIO, INC. (FGEN) Delisted Chief Executive Officer 16,101 $9.75 $157.0K -$828.9K 22 2023-07-10
LLY SVP&Pres, LillyDiab & LillyUSA 163,121 $1196.03 $195.10M -$13.33M 43 2019-02-20

Recent Filings

65 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-07-10 KYNTRA BIO, INC. (FGEN) Delisted Sell (S) −1,880 -$5.3K EDGAR
2023-06-09 KYNTRA BIO, INC. (FGEN) Delisted Sell (S) −8,897 -$151.6K EDGAR
2023-04-11 KYNTRA BIO, INC. (FGEN) Delisted Sell (S) −1,869 -$36.5K EDGAR
2023-03-23 KYNTRA BIO, INC. (FGEN) Delisted Sell (S) −19,489 -$393.6K EDGAR
2023-03-10 KYNTRA BIO, INC. (FGEN) Delisted Mixed +4,088 -$1.16M EDGAR
2023-02-23 KYNTRA BIO, INC. (FGEN) Delisted Grant (A) +85,300 $0 EDGAR
2023-01-10 KYNTRA BIO, INC. (FGEN) Delisted Sell (S) −1,538 -$30.7K EDGAR
2022-12-09 KYNTRA BIO, INC. (FGEN) Delisted Sell (S) −2,543 -$40.2K EDGAR
2022-10-11 KYNTRA BIO, INC. (FGEN) Delisted Tax (F) −1,296 -$18.5K EDGAR
2022-09-08 KYNTRA BIO, INC. (FGEN) Delisted Tax (F) −1,772 -$21.7K EDGAR
Showing 1–10 of 65
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.